Obesity Prevention for Children with Developmental Disabilities

Aviva Must1, Carol Curtin2, Kristie Hubbard3

  • 1Department of Public Health and Community Medicine, Tufts University School of Medicine, 136 Harrison Avenue, Boston, MA 02111.

Current Obesity Reports
|December 23, 2014
PubMed

Insights

Preventing obesity in children with developmental disabilities (DD) is crucial. Tailored strategies are needed to address unique risk factors and adapt interventions for better health outcomes.

Area of Science:

  • Public Health
  • Pediatrics
  • Disability Studies

Background:

  • Obesity is a significant public health concern, particularly for children with developmental disabilities (DD).
  • Children with intellectual disabilities (ID) and autism spectrum disorder (ASD) exhibit obesity prevalence rates equal to or exceeding those of typically developing peers.
  • The implications of obesity in this population extend to health status, independent living, and overall quality of life.

Purpose of the Study:

  • To review known classic and unique risk factors for childhood obesity in children with DD.
  • To synthesize evidence regarding dietary, physical activity, sedentary behavior, family, and medication-related factors.
  • To advocate for tailored primary prevention strategies at multiple levels.

Main Methods:

  • Literature review of existing evidence on childhood obesity in children with DD.
  • Analysis of risk factors including behavioral, environmental, and medical aspects.
  • Synthesis of findings to inform prevention approaches.

Main Results:

  • Children with DD face substantial obesity risks, influenced by a combination of common and specific factors.
  • Dietary habits, physical activity levels, sedentary behaviors, family influences, and medication use are key contributors.
  • Existing interventions may require adaptation to effectively address the needs of this population.

Conclusions:

  • Primary prevention of obesity in children with DD is essential and requires a multi-faceted approach.
  • Intervention strategies must be tailored to the individual/family, school, and community levels.
  • Adapting current intervention models is necessary for successful obesity prevention in children with DD.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
351
Learning Disabilities01:25

Learning Disabilities

Learning disabilities are cognitive disorders caused by neurological impairments that affect cognitive functions like language and reading, without indicating overall intellectual or developmental challenges. These disabilities differ from global intellectual or developmental disabilities as they are limited to distinct cognitive functions. Common learning disabilities include dysgraphia, dyslexia, and dyscalculia, each of which impacts unique aspects of learning.
Dyslexia
Dyslexia is a...
764
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
310
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
2.3K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
425